| Prev Close | 216.06 |
| Open | 215.46 |
| Day Low/High | 208.59 / 217.29 |
| 52 Wk Low/High | 104.28 / 240.76 |
| Volume | 1.28M |
Constellation Brands, Inc. Class A (STZ)
211.15
4.91
2.27
NYSE
| Exchange | NYSE |
| Shares Outstanding | 193.91B |
| Market Cap | 42.30B |
| P/E Ratio | 21.86 |
| Div & Yield | N.A. (N.A) |
How to Play Tilray With Options
A so-called 'ratio-put spread' looks good here.
Play Tilray Using a 'Ratio-Put Spread'
This options trade combines some upside with a chance to buy TLRY at a decent price.
Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers
The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.
Experts Are High on Cannabis Stocks' 2019 Prospects
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
Coke's Flirtation with Cannabis Reaffirms What We Already Know
The latest reports about Coke looking into cannabis confirms a broader industry trend.
Jim Cramer: Be Cautious Before You Invest in the Budding Cannabis Industry
You don't want your money to go up in smoke.
3 Big-Name Stocks to Consider Shorting
A brewer facing challenges, a banking giant and a retail behemoth are ripe for downside plays.
Cannabis for Traders, Cannabis for Investors: Market Recon
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
Mainstream Research Just Doesn't Get Canopy Growth
Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.
Canada's Hexo Pursues Additional JV Cannabis Deals After Molson
Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.
Advisors, Analysts Brush Off Nike Controversy, Say Selloff Is Short-Lived
Analysts and advisors stand by Nike as NFL.
Tilray Feeds Deal-Making Speculation on Analyst Call
Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.
Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend
Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?
Jim Cramer: The Great Ones Disrupt Their Own
Two companies, PepsiCo and Constellation Brands, are disrupting their own businesses and getting no credit whatsoever for doing so.
'Fear of Missing Out': Analysts Question Constellation's Big Canopy Play
Even bullish analysts are cautious on Constellation's big cannabis bet.
Here's How to Play Canopy Growth If You Missed Wednesday's Big Pop-Up
Odds are good that you'll make at least 8% in 37 days using this put play.
How to Play Canopy Growth Using Put Options
Odds are good that you'll make at least 8% in 37 days using this play.
Constellation Brands Invests $4 Billion in Canopy Growth: Is Takeover Imminent?
Constellation Brand's bigger stake in Canopy has analysts mulling the prospects of a takeover.
Canopy Growth Soars Without Any Advance Clues - Exercise Patience
With the price of CGC up around 8% this morning a fresh look at the charts is in order.
Canopy Growth Is a Positive Spot in this Sea of Red
CGC and STZ should both remain 'go to' plays on the marijuana industry.
From Cannabis to China: Beer Companies Chase New Growth Opportunities
Beer companies are going to greater lengths to grow.
Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players
Tilray is full steam ahead in taking on some established players in the food and drug industry. CEO Brendan Kennedy discusses the company's efforts to grow.
Alcohol Industry's Fresh Pro Pot Rhetoric May Seed Product Convergence
A historic endorsement of pot legalization by a key wine and beer trade group marks the latest foray by alcohol producers into cannabis.
Jim Cramer: Here's What You Need to Know About Canopy Growth's Stock
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer interviewed marijuana company Canopy Growth's CEO Bruce Linton.
3 Stocks to Buy to Steer Clear of Trade Wars: Market Recon
The U.S. and China will eventually negotiate, but until then, here is how to play it.
Cannabis Beer Is Giving Investors a Fresh Buzz
The food and beverages space offers huge potential for those curious about cannabis but who do not want to smoke.
The Future of Stocks (At Least for the July 4 Holiday Week)
Trade war fears dominated talk in Tuesday's holiday shortened session. With July 4 approaching, TheStreet looks at a host of stocks you should consider researching further.
